Metabonomics and toxicology

Methods in Molecular Biology

Volumn 1277, Issue , 2015, Pages 209-231

  Zhao, Liang ^a   Hartung, Thomas ^a  

^a NONE

Author keywords

Mass spectrometry; Mechanism of toxicity; Metabonomics metabolomics; Omics technology; Pathways of toxicity; Systems biology; Toxicology

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; MASS SPECTROMETRY; METABOLOMICS; METABONOMICS; PRIORITY JOURNAL; SYSTEMS BIOLOGY; TOXICITY TESTING; TOXICOLOGY; BIOLOGY; HUMAN; PROCEDURES; PUBLICATION; QUALITY CONTROL; STANDARD; STATISTICS;

COMPUTATIONAL BIOLOGY; HUMANS; METABOLOMICS; PUBLICATIONS; QUALITY CONTROL; REFERENCE STANDARDS; STATISTICS AS TOPIC; TOXICOLOGY;

EID: 84922954394     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2377-9_15     Document Type: Article

References (80)

1. Hartung T (2009) Toxicology for the twentyfirst century. Nature 460: 208-212.
2. Davis M, Boekelheide K, Boverhof DR et al (2013) The new revolution in toxicology: the good, the bad, and the ugly. Ann N Y Acad Sci 1278: 11-24.
3. Hartung T, McBride M (2011) Food for thought… on mapping the human toxome. ALTEX 28: 83-93.
4. Kleensang A, Maertens A, Rosenberg M et al. (2014) t4 Workshop Report: Pathways of toxicity. ALTEX 31: 53-61.
5. Hartung T (2010) Food for thought… on alternative methods for chemical safety testing. ALTEX 27: 3-14.
6. Ramirez T, Daneshian M, Kamp H et al (2012) Metabolomics in toxicology and preclinical research. ALTEX 30: 209-225.
7. Hartung T (2008) Food for thought… on animal tests. ALTEX 25: 3-9.
8. Bracken MB (2009) Why animal studies are often poor predictors of human reactions to exposure. J R Soc Med 102: 120-122.
9. Bucher JR (2002) The national toxicology program rodent bioassay. Ann N Y Acad Sci 982: 198-207.
10. Bottini AA, Hartung T (2009) Food for thought… on economics of animal testing. ALTEX 26: 3-16.
11. Basketter DA, Clewell H, Kimber I et al (2012) t (4) report a roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. ALTEX 29: 3-91.
12. Stevens JL (2006) Future of toxicology mechanisms of toxicity and drug safety: where do we go from here? Chem Res Toxicol 19: 1393-1401.
13. Hartung T (2013) Food for thought… look back in anger: what clinical studies tell us about preclinical work. ALTEX 30: 275.
14. Hartung T, Luechtefeld T, Maertens A et al (2013) Food for thought… integrated testing strategies for safety assessments. ALTEX 30: 3.
15. Hartung T, van Vliet E, Jaworska J et al (2012) Food for thought…systems toxicology. ALTEX 29: 119.
16. van Vliet E (2011) Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century. ALTEX 28: 17.
17. Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85: 809-822.
18. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189.
19. Nicholson JK, Connelly J, Lindon JC et al (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1: 153-161.
20. Holmes E, Wilson ID, Nicholson JK (2008) Metabolic phenotyping in health and disease. Cell 134: 714-717.
21. Nicholson JK (2006) Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2: 52. doi: 10. 1038/msb4100095.
22. Fiehn O (2002) Metabolomics: the link between genotypes and phenotypes. Plant Mol Biol 48: 155-171.
23. Ramsden JJ (2004) Metabolomics and metabonomics. In: Bioinformatics: an introduction. Springer Netherlands, p 221-226. doi: 10. 1007/978-1-4020-2950-9_15.
24. Friedrich N (2012) Metabolomics in diabetes research. J Endocrinol 215: 29-42.
25. Koal T, Deigner HP (2010) Challenges in mass spectrometry based targeted metabolomics. Curr Mol Med 10: 216-226.
26. Wang W, Zhang W, Liu J et al (2013) Metabolomic changes in follicular fluid induced by soy isoflavones administered to rats from weaning until sexual maturity. Toxicol Appl Pharmacol 269: 280-289.
27. Crockford DJ, Maher AD, Ahmadi KR et al (2008) 1H NMR and UPLC-MSE statistical heterospectroscopy: characterization of drug metabolites (Xenometabolome) in epidemiological studies. Anal Chem 80: 6835-6844.
28. Dunn WB, Ellis DI (2005) Metabolomics: current analytical platforms and methodologies. Trends Anal Chem 24: 285-294.
29. Dunn WB, Bailey NJ, Johnson HE (2005) Measuring the metabolome: current analytical technologies. Analyst 130: 606-625.
30. Bouhifd M, Hartung T, Hogberg HT et al (2013) Review: toxicometabolomics. J Appl Toxicol 33: 1365-1383.
31. Southam AD, Lange A, Hines A et al (2011) Metabolomics reveals target and off-target toxicities of a model organophosphate pesticide to roach (Rutilus rutilus): implications for biomonitoring. Environ Sci Technol 45: 3759-3767.
32. Begriche K, Massart J, Robin MA et al (2011) Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54: 773-794.
33. Lin S, Yang Z, Liu H et al (2011) Metabolomic analysis of liver and skeletal muscle tissues in C57BL/6J and DBA/2J mice exposed to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Mol Biosyst 7: 1956-1965.
34. Li F, Lu J, Ma X (2011) Profiling the reactive metabolites of xenobiotics using metabolomic technologies. Chem Res Toxicol 24: 744-751.
35. Griffiths WJ, Koal T, Wang Y et al (2010) Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 49: 5426-5445.
36. Chen J, Zhang X, Cao R et al (2011) Serum 27-nor-5beta-cholestane-3, 7, 12, 24, 25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. J Proteome Res 10: 2625-2632.
37. Lucio M, Fekete A, Weigert C et al (2010) Insulin sensitivity is reflected by characteristic metabolic fingerprints: a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One 5: e13317.
38. Issaq HJ, Waybright TJ, Veenstra TD (2011) Cancer biomarker discovery: opportunities and pitfalls in analytical methods. Electrophoresis 32: 967-975.
39. Woo HM, Kim KM, Choi MH et al (2009) Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta 400: 63-69.
40. Wang X, Zhang A, Han Y et al (2012) Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 11: 370-380.
41. Hollywood K, Brison DR, Goodacre R (2006) Metabolomics: current technologies and future trends. Proteomics 6: 4716-4723.
42. Kim HK, Choi YH, Verpoorte R (2011) NMR-based plant metabolomics: where do we stand, where do we go? Trends Biotechnol 29: 267-275.
43. Scalbert A, Brennan L, Fiehn O et al (2009) Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 5: 435-458.
44. Wishart DS (2008) Quantitative metabolomics using NMR. Trends Anal Chem 27: 228-237.
45. Hanzlik RP, Bhatia P, Stitt R et al (1980) Biotransformation and excretion of methylcyclopentadienyl manganese tricarbonyl in the rat. Drug Metab Dispos 8: 428-433.
46. Fukuhara K, Ohno A, Ando Y et al (2011) A 1H NMR-based metabolomics approach for mechanistic insight into acetaminopheninduced hepatotoxicity. Drug Metab Pharmacokinet 26: 399-406.
47. Liu X, Zhang L, You L et al (2011) Toxicological responses to acute mercury exposure for three species of Manila clam Ruditapes philippinarum by NMR-based metabolomics. Environ Toxicol Pharmacol 31: 323-332.
48. Barba I, Fernandez-Montesinos R, Garcia-Dorado D et al (2008) Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics. J Cell Mol Med 12: 1477-1485.
49. Neerathilingam M, Volk DE, Sarkar S et al (2010) 1H NMR-based metabonomic investigation of tributyl phosphate exposure in rats. Toxicol Lett 199: 10-16.
50. Beger RD, Sun J, Schnackenberg LK (2010) Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 243: 154-166.
51. Serkova NJ, Van Rheen Z, Tobias M et al (2008) Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 295: L152-L161.
52. Griffin JL, Kauppinen RA (2007) A metabolomics perspective of human brain tumours. FEBS J 274: 1132-1139.
53. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48: 653-683.
54. Roux A, Lison D, Junot C et al (2011) Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: a review. Clin Biochem 44: 119-135.
55. Patterson AD, Lanz C, Gonzalez FJ et al (2010) The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev 29: 503-521.
56. Singh OV (2006) Proteomics and metabolomics: the molecular make-up of toxic aromatic pollutant bioremediation. Proteomics 6: 5481-5492.
57. Chen C, Gonzalez FJ, Idle JR (2007) LC-MSbased metabolomics in drug metabolism. Drug Metab Rev 39: 581-597.
58. Crockford DJ, Holmes E, Lindon JC et al (2006) Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem 78: 363-371.
59. West PR, Weir AM, Smith AM et al (2010) Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol Appl Pharmacol 247: 18-27.
60. Wang J, Reijmers T, Chen L et al (2009) Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics. Metabolomics 5: 407-418.
61. Dunn WB, Wilson ID, Nicholls AW et al (2012) The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis 4: 2249-2264.
62. Fan TW-M (2012) Considerations of sample preparation for metabolomics investigation. In: the handbook of metabolomics. Springer, p 7-27.
63. Lafaye A, Junot C, Gall BRL et al. (2003) Metabolite profiling in rat urine by liquid chromatography/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity. Rapid Commun Mass Spectrom 17: 2541-2549.
64. Chen C, Krausz KW, Idle JR et al (2008) Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. J Biol Chem 283: 4543-4559.
65. Laaksonen R, Katajamaa M, Päivä H et al (2006) A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS One 1: e97.
66. Teng Q, Huang W, Collette TW et al (2009) A direct cell quenching method for cellculture based metabolomics. Metabolomics 5: 199-208.
67. Prasad Maharjan R, Ferenci T (2003) Global metabolite analysis: the influence of extraction methodology on metabolome profiles of Escherichia coli. Anal Biochem 313: 145-154.
68. Jackson JE (2005) A user's guide to principal components. John Wiley & Sons, New York, NY.
69. Kaufman L, Rousseeuw PJ (2009) Finding groups in data: an introduction to cluster analysis. John Wiley & Sons, New York, NY.
70. Lutz U, Lutz RW, Lutz WK (2006) Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender. Anal Chem 78: 4564-4571.
71. Trygg J, Wold S (2002) Orthogonal projections to latent structures (O-PLS). J Chemometrics 16: 119-128.
72. Shockcor JP, Holmes E (2002) Metabonomic applications in toxicity screening and disease diagnosis. Curr Top Med Chem 2: 35-51.
73. Robertson DG, Reily MD, Sigler RE et al (2000) Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 57: 326-337.
74. Van Vliet E, Morath S, Eskes C et al (2008) A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicology 29: 1-12.
75. Boudonck KJ, Mitchell MW, Német L et al (2009) Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 37: 280-292.
76. Vangala S, Tonelli A (2007) Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity? AAPS J 9: E284-E297.
77. Nicholls AW, Holmes E, Lindon JC et al (2001) Metabonomic investigations into hydrazine toxicity in the rat. Chem Res Toxicol 14: 975-987.
78. Sieber M, Hoffmann D, Adler M et al (2009) Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci 109: 336-349.
79. Antoine D, Mercer A, Williams D et al (2009) Mechanism-based bioanalysis and biomarkers for hepatic chemical stress. Xenobiotica 39: 565-577.
80. Lujan R, Shigemoto R, Lopez-Bendito G (2005) Glutamate and GABA receptor signalling in the developing brain. Neuroscience 130: 567-580.